InvestSMART

Nuheara Limited (ASX: NUH) - Announcements

DELISTED - Current share price for NUH : $0.081

ASX company news and announcements for Nuheara Limited (NUH) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Nuheara Limited (NUH) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Nuheara Limited (NUH), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Nuheara Limited (NUH)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Application for quotation of securities - NUH 9 Feb 2022 5:55PM $0.017 $0.081 risen by 376.47%
- Presentation - 2022FY Q2 Results 1 Feb 2022 12:44PM $0.016 $0.081 risen by 406.25%
- Clinical Trial Validates Nuheara Self-Fitted Hearing Aids 1 Feb 2022 9:49AM $0.016 $0.081 risen by 406.25%
- Quarterly Activities Report and Appendix 4C 31 Jan 2022 9:03AM $0.016 $0.081 risen by 406.25%
- Q2 FY22 Business Update and Investor Briefing Details 28 Jan 2022 12:38PM $0.015 $0.081 risen by 458.62%
- Change of Director's Interest Notice x 4 27 Jan 2022 2:55PM $0.015 $0.081 risen by 458.62%
- Application for quotation of securities - NUH 25 Jan 2022 8:19AM $0.016 $0.081 risen by 406.25%
- Nuheara Completes Share Purchase Plan 24 Jan 2022 12:00PM $0.016 $0.081 risen by 406.25%
- Nuheara Clinical Trial and FDA 510(K) Pathway Update 6 Jan 2022 9:47AM $0.016 $0.081 risen by 406.25%
- Notification regarding unquoted securities - NUH 6 Jan 2022 9:27AM $0.016 $0.081 risen by 406.25%
- Notification of cessation of securities - NUH 5 Jan 2022 8:07PM $0.016 $0.081 risen by 406.25%
- Ceasing to be a substantial holder 31 Dec 2021 11:16AM $0.017 $0.081 risen by 376.47%
- Share Purchase Plan Offer Document 31 Dec 2021 9:00AM $0.017 $0.081 risen by 376.47%
- Section 708A(5)(e) Notice 31 Dec 2021 8:57AM $0.017 $0.081 risen by 376.47%
- Application for quotation of securities - NUH 31 Dec 2021 8:45AM $0.017 $0.081 risen by 376.47%
- Section 708A(5)(e) Notice 29 Dec 2021 7:59PM $0.017 $0.081 risen by 376.47%
- Application for quotation of securities - NUH 29 Dec 2021 7:53PM $0.017 $0.081 risen by 376.47%
- Nuheara Undertakes Capital Raising to Support Growth 23 Dec 2021 9:41AM $0.019 $0.081 risen by 326.32%
- Proposed issue of securities - NUH 23 Dec 2021 9:30AM $0.019 $0.081 risen by 326.32%
- Presentation - Company Update 7 Dec 2021 1:20PM $0.019 $0.081 risen by 326.32%
- Nuheara Secures Global Supply Agreement With Sonova 6 Dec 2021 8:44AM $0.019 $0.081 risen by 326.32%
- Nuheara Receives $1.74 Million R&D Tax Cash Rebate 1 Dec 2021 9:18AM $0.019 $0.081 risen by 326.32%
- Nuheara Clinical Trial and FDA 510(K) Pathway Update 25 Nov 2021 10:13AM $0.020 $0.081 risen by 305%
- Change in substantial holding 16 Nov 2021 4:50PM $0.019 $0.081 risen by 326.32%
- Nuheara to Present at TechOpps 2021 Virtual Conference 9 Nov 2021 9:44AM $0.021 $0.081 risen by 285.71%

201 - 225 of 620 results

Page 9 of 25

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.